Refine by
Clinics Medical Practices Articles & Analysis
165 news found
Carolina Reduzzi, an Assistant Professor of Cancer Biology Research in Medicine and Director of the Liquid Biopsy Platform of the Englander Institute for Precision Medicine (EIPM) at Weill Cornell Medicine. “The development and clinical validation of a potentially more sensitive and informative method for detecting minimal residual disease in patients with EBC may help ...
Summary The world of dental and clinical illumination has evolved dramatically with the introduction of the VAL™ (Voice-Activated Light) Digital LED Headlight System. Designed with cutting-edge technology, this revolutionary product allows clinicians to activate their headlight system using a simple voice command, significantly enhancing workflow and ...
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS”, Elizabeth Ratsma, Pre-Registration Clinical Scientist – Cancer Genomics and Charlotte Flanagan, PhD, Innovation Lead, from The Royal Marsden NHS Foundation Trust. The poster was recently presented at the ESMO ...
Idiopathic pulmonary fibrosis (IPF) remains a devastating condition with limited treatment options, often leading to a grim prognosis. However, a recent study by Milman-Krentsis (2024) offers a beacon of hope, demonstrating the potential of lung cell transplantation as a therapeutic intervention for lung fibrosis. Utilizing two distinct mouse models—one treated with bleomycin and another ...
CanaQuest Medical Corp (“CanaQuest” or the “Company”) (OTC: CANQF), is pleased to announce strategic additions to its executive team with expertise in conducting clinical trials and US FDA drug approval success. The team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare ...
Tempus is now offering these two IHC tests, which are recommended in clinical guidelines for several cancer types and may be ordered for other cancer types at the clinician’s discretion. ...
ByTempus
In September 2023, Tempus and AstraZeneca initiated a pilot program to leverage Next to identify this specific care gap at participating provider sites, using AI to scan unstructured clinical data to understand which patients may be eligible for testing based on clinical guidelines, and notifying treating physicians to inform care. ...
ByTempus
Summary SurgiTel’s hybrid loupes incorporate our patented suspended magnification technology by positioning magnification oculars at the lowest point within a rimless bottom frame. This strategic placement, combined with the pantoscopic tilt of our lenses, creates an ergonomic loupe with a steep declination angle that is comparable to a deflection loupe (see Figure 4). The suspended ...
Each formulation is meticulously designed to meet the unique needs of different medications and patient populations,” said the Marketing Director of CD Formulation. Excipients for Liquid Dosage Form Liquid preparations are currently the most widely used in clinical practice. In the realm of liquid dosage forms, CD Formulation offers a ...
Microsphere formulation has been highlighted as a promising dosage form in clinical practice due to its ability to significantly improve patient convenience and compliance. As a trustworthy partner in the field of pharmaceutical formulation, CD Formulation has newly introduced a range of raw materials for the production of microspheres and microneedles, which are highly expected to advance ...
Hyperpigmentation dermatoses are a common clinical problem today, including freckles, nevus of Ota, age spots and coffee spots, which have a significant impact on patients' facial aesthetics and psychological well-being. Traditionally, patients with pigmentation disorders have been treated with implants, grinding and freezing, but these treatment options are prone to postoperative pigmentation ...
Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging. “Always bearing in mind that what customers truly need is the top ...
A key presentation highlights new clinical data on the novel development compound gadoquatrane, a next generation macrocyclic gadolinium-based contrast agent (GBCA) which is currently in Phase II of clinical development and planned to enter Phase III later this year. ...
ByBayer AG
IPL photorejuvenation machine is the earliest laser skin treatment equipment. It mainly uses IPL intense pulsed light to hit the skin, which has the effect of removing freckles and sealing blood vessels, that is, improving the state of vasodilation. It can also shrink pores, make the skin smoother, and improve the aging state of the skin. Bvlaser is a professional IPL beauty machine factory ...
A sure sign of a quality organization is the ability to measure its progress and success. “In business, words are words; explanations are explanations, promises are promises, but only performance is reality,” according to Harold S. Geneen, CEO of International Telephone and Telegraph Corp. With the continuous upward trend in productivity of the pharmaceutical ...
It is easy to perform in everyday clinical practice and can be used in various clinical settings, such as inconclusive findings in previous imaging procedures, or preoperative assessment of the extent of the disease. ...
ByBayer AG
Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with One GI®, a gastroenterology management services organization (MSO), to bring its AI Recruitment (AIR) technology to One GI’s clinical research. Initially, One GI® will use AIR at Gastro One, one of One GI’s clinical research sites in Memphis, ...
We performed 2 clinical trials in leading neurorehabilitation hospitals in Germany and Spain proving safety, feasibility and usability of the exoskeleton in a clinical setting, and showing significant improvements in clinical outcomes and benefits in rehabilitation. A Multicentric Clinical investigation in Institut Guttmann (Spain) and Heidelberg University Hospital (Germany), leading European ...
I had been using an exoskeleton in my clinical practice for many years, and at some point, I had considered studying something related to biomedical engineering. ...
The next steps are to carry out a clinical trial with 50 patients and in the near future to be able to bring these advances to the market. ...